Peter Ruppersberg

Founder at WaveMedix

Saint-Légier-La Chiésaz, Vaud, Switzerland

About

Since March 2025 Founder & CEO Wavemedix Inc. Wilmington (DE). From May 2015 Founder & CEO Ablacon Inc. Denver (CO) later renamed Cortex EP Inc. Sold to BSCI in January 2025 From April 2013 Executive Director Corporate Development, and later CEO Sophono Inc. Boulder (CO). Sold Sophono Inc. to Medtronic in April 2015. From March 2010 to November 2012, CEO of Valtronic Group January 2009 to February 2010 partner at Patrimonium Medical Technology Advisors AG, Baar. Since 1999 Private Equity Investor and founder of several companies. 2001 to 2009 investment partner for the L-Bank of Baden Württemberg. Active Chairman and Restructuring Manager of Seleon GmbH, Greenovation GmbH and Flyion GmbH. Before Professor of Biophysics and Physiology, University of Tübingen. In 1991 Member of Nobel Prize winning Max-Planck-Institute team (single channel recording from neurons). Inventor of a novel therapeutic principle (Treatment of Tinnitus). Specialties: Medical Technologies.

Experience

  • Founder and CEO at WaveMedix
    Mar 2025 - Present · 1 yr 4 mos

    Founder and Chief Executive Officer

  • Cortex - acquired by Boston Scientific (Remote)
    • Technical Consultant
      Jan 2025 - Present · 1 yr 6 mos

    • Chief Scientific Officer
      Jan 2024 - Feb 2025 · 1 yr 2 mos

  • Ablacon (9 yrs 1 mo)
    • Chief Scientific Officer
      Apr 2019 - May 2024 · 5 yrs 2 mos

    • Founder and CEO
      May 2015 - Apr 2019 · 4 yrs

  • Chief Executive Officer at Sophono
    Apr 2013 - Apr 2015 · 2 yrs 1 mo

  • Chief Executive Officer at Valtronic Technologies SA
    Mar 2010 - Mar 2013 · 3 yrs 1 mo